-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Iterum Therapeutics plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2016 to Q1 2025.
- Iterum Therapeutics plc Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was -$8.39M, a 216% decline year-over-year.
- Iterum Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $26.7M, a 2481% increase from 2023.
- Iterum Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1.03M.
- Iterum Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.82M, a 102% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)